Jazz takes on Watson at New Jersey court to protect Xyrem

30-06-2015

Jazz takes on Watson at New Jersey court to protect Xyrem

Ollyy / Shutterstock.com

Jazz Pharmaceuticals has sued Watson Laboratories for patent infringement in order to stop the company making a generic version of its flagship product Xyrem (sodium oxybate).


Xyrem, ANDA, Jazz Pharmaceuticals, Watson Laboratories, US District Court for the District of New Jersey, patents

LSIPR